The IHC results indicated that DDX17 mostly located in the nucleus of tumor cells, and DDX17 expression progressively increased across different pathological stages of HCC, unlike the adjacent normal tissues (Fig. 1E). Here, DDX17 is linked to hepatocellular carcinoma.